Automation of radiation treatment planning for rectal cancer.
automation
deep learning
field-in-field
radiotherapy
rectal cancer
Journal
Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
10
06
2022
received:
22
03
2022
accepted:
13
06
2022
pubmed:
10
7
2022
medline:
28
9
2022
entrez:
9
7
2022
Statut:
ppublish
Résumé
To develop an automated workflow for rectal cancer three-dimensional conformal radiotherapy (3DCRT) treatment planning that combines deep learning (DL) aperture predictions and forward-planning algorithms. We designed an algorithm to automate the clinical workflow for 3DCRT planning with field aperture creations and field-in-field (FIF) planning. DL models (DeepLabV3+ architecture) were trained, validated, and tested on 555 patients to automatically generate aperture shapes for primary (posterior-anterior [PA] and opposed laterals) and boost fields. Network inputs were digitally reconstructed radiographs, gross tumor volume (GTV), and nodal GTV. A physician scored each aperture for 20 patients on a 5-point scale (>3 is acceptable). A planning algorithm was then developed to create a homogeneous dose using a combination of wedges and subfields. The algorithm iteratively identifies a hotspot volume, creates a subfield, calculates dose, and optimizes beam weight all without user intervention. The algorithm was tested on 20 patients using clinical apertures with varying wedge angles and definitions of hotspots, and the resulting plans were scored by a physician. The end-to-end workflow was tested and scored by a physician on another 39 patients. The predicted apertures had Dice scores of 0.95, 0.94, and 0.90 for PA, laterals, and boost fields, respectively. Overall, 100%, 95%, and 87.5% of the PA, laterals, and boost apertures were scored as clinically acceptable, respectively. At least one auto-plan was clinically acceptable for all patients. Wedged and non-wedged plans were clinically acceptable for 85% and 50% of patients, respectively. The hotspot dose percentage was reduced from 121% (σ = 14%) to 109% (σ = 5%) of prescription dose for all plans. The integrated end-to-end workflow of automatically generated apertures and optimized FIF planning gave clinically acceptable plans for 38/39 (97%) of patients. We have successfully automated the clinical workflow for generating radiotherapy plans for rectal cancer for our institution.
Identifiants
pubmed: 35808871
doi: 10.1002/acm2.13712
pmc: PMC9512348
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13712Subventions
Organisme : the MD Anderson Cancer Center Institutional Research Grant
Informations de copyright
© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.
Références
Jpn J Radiol. 2010 May;28(4):283-9
pubmed: 20512546
Med Dosim. 2004 Winter;29(4):265-70
pubmed: 15528068
Semin Radiat Oncol. 1993 Jan;3(1):42-47
pubmed: 10717051
Pract Radiat Oncol. 2020 Sep - Oct;10(5):e415-e424
pubmed: 32450365
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818810391
pubmed: 30384804
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Jpn J Radiol. 2012 Apr;30(3):218-26
pubmed: 22183829
Pract Radiat Oncol. 2021 Jan-Feb;11(1):13-25
pubmed: 33097436
Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):187-94
pubmed: 10656392
Radiat Oncol J. 2013 Dec;31(4):252-9
pubmed: 24501715
Jpn J Clin Oncol. 2008 Feb;38(2):158-63
pubmed: 18216025
J Appl Clin Med Phys. 2022 Sep;23(9):e13712
pubmed: 35808871
J Glob Oncol. 2019 Jan;5:1-9
pubmed: 30629457
Med Dosim. 2004 Summer;29(2):109-14
pubmed: 15191757
Phys Med. 2013 Nov;29(6):577-82
pubmed: 23219336
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cancer Res Ther. 2009 Jan-Mar;5(1):20-3
pubmed: 19293484
Australas Phys Eng Sci Med. 2008 Dec;31(4):317-24
pubmed: 19239058
Radiat Oncol. 2019 Mar 27;14(1):53
pubmed: 30917848
Med Phys. 2019 Sep;46(9):3767-3775
pubmed: 31077593